FDA ‘Encouraging Evergreening’ With Strength Definition – Boehringer Ingelheim
Minor Concentration Changes Being Used As ‘Anticompetitive Tactic’
The FDA's definition of strength for injectable biologics is "arbitrary and capricious," Boehringer insists. • Source: Shutterstock 
